The global market for Pandemic Influenza Vaccine was valued at US$ 8955 million in the year 2024 and is projected to reach a revised size of US$ 12990 million by 2031, growing at a CAGR of 5.5% during the forecast period.

Pandemic Influenza Vaccine Market

Global key players of Pandemic Influenza Vaccine include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pandemic Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pandemic Influenza Vaccine.

The Pandemic Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pandemic Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pandemic Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pandemic Influenza Vaccine Market Report

Report Metric	Details
Report Name	Pandemic Influenza Vaccine Market
Accounted market size in year	US$ 8955 million
Forecasted market size in 2031	US$ 12990 million
CAGR	5.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Trivalent Influenza Vaccine Quadrivalent Influenza Vaccine
Segment by Application	6 Months to 3 Years > 3 Years
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pandemic Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pandemic Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pandemic Influenza Vaccine Market growing?

Ans: The Pandemic Influenza Vaccine Market witnessing a CAGR of 5.5% during the forecast period 2025-2031.

What is the Pandemic Influenza Vaccine Market size in 2031?

Ans: The Pandemic Influenza Vaccine Market size in 2031 will be US$ 12990 million.

What is the market share of major companies in Pandemic Influenza Vaccine Market?

Ans: The top five players hold a share about 75%.

What is the Pandemic Influenza Vaccine Market share by region?

Ans: North America is the largest market, has a share about 50%.

Who are the main players in the Pandemic Influenza Vaccine Market report?

Ans: The main players in the Pandemic Influenza Vaccine Market are Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics

What are the Application segmentation covered in the Pandemic Influenza Vaccine Market report?

Ans: The Applications covered in the Pandemic Influenza Vaccine Market report are 6 Months to 3 Years, > 3 Years

What are the Type segmentation covered in the Pandemic Influenza Vaccine Market report?

Ans: The Types covered in the Pandemic Influenza Vaccine Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

1 Pandemic Influenza Vaccine Market Overview

1.1 Product Definition

1.2 Pandemic Influenza Vaccine by Type

1.2.1 Global Pandemic Influenza Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Trivalent Influenza Vaccine

1.2.3 Quadrivalent Influenza Vaccine

1.3 Pandemic Influenza Vaccine by Application

1.3.1 Global Pandemic Influenza Vaccine Market Value by Application (2024 VS 2031)

1.3.2 6 Months to 3 Years

1.3.3 > 3 Years

1.4 Global Pandemic Influenza Vaccine Market Size Estimates and Forecasts

1.4.1 Global Pandemic Influenza Vaccine Revenue 2020-2031

1.4.2 Global Pandemic Influenza Vaccine Sales 2020-2031

1.4.3 Global Pandemic Influenza Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Pandemic Influenza Vaccine Market Competition by Manufacturers

2.1 Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pandemic Influenza Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pandemic Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pandemic Influenza Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pandemic Influenza Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Pandemic Influenza Vaccine, Date of Enter into This Industry

2.8 Global Pandemic Influenza Vaccine Market Competitive Situation and Trends

2.8.1 Global Pandemic Influenza Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pandemic Influenza Vaccine Players Market Share by Revenue

2.8.3 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pandemic Influenza Vaccine Market Scenario by Region

3.1 Global Pandemic Influenza Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pandemic Influenza Vaccine Sales by Region: 2020-2031

3.2.1 Global Pandemic Influenza Vaccine Sales by Region: 2020-2025

3.2.2 Global Pandemic Influenza Vaccine Sales by Region: 2026-2031

3.3 Global Pandemic Influenza Vaccine Revenue by Region: 2020-2031

3.3.1 Global Pandemic Influenza Vaccine Revenue by Region: 2020-2025

3.3.2 Global Pandemic Influenza Vaccine Revenue by Region: 2026-2031

3.4 North America Pandemic Influenza Vaccine Market Facts & Figures by Country

3.4.1 North America Pandemic Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pandemic Influenza Vaccine Sales by Country (2020-2031)

3.4.3 North America Pandemic Influenza Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Pandemic Influenza Vaccine Market Facts & Figures by Country

3.5.1 Europe Pandemic Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pandemic Influenza Vaccine Sales by Country (2020-2031)

3.5.3 Europe Pandemic Influenza Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Pandemic Influenza Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pandemic Influenza Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Pandemic Influenza Vaccine Market Facts & Figures by Country

3.7.1 Latin America Pandemic Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pandemic Influenza Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Pandemic Influenza Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Pandemic Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pandemic Influenza Vaccine Sales by Type (2020-2031)

4.1.1 Global Pandemic Influenza Vaccine Sales by Type (2020-2025)

4.1.2 Global Pandemic Influenza Vaccine Sales by Type (2026-2031)

4.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Pandemic Influenza Vaccine Revenue by Type (2020-2031)

4.2.1 Global Pandemic Influenza Vaccine Revenue by Type (2020-2025)

4.2.2 Global Pandemic Influenza Vaccine Revenue by Type (2026-2031)

4.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Pandemic Influenza Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pandemic Influenza Vaccine Sales by Application (2020-2031)

5.1.1 Global Pandemic Influenza Vaccine Sales by Application (2020-2025)

5.1.2 Global Pandemic Influenza Vaccine Sales by Application (2026-2031)

5.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Pandemic Influenza Vaccine Revenue by Application (2020-2031)

5.2.1 Global Pandemic Influenza Vaccine Revenue by Application (2020-2025)

5.2.2 Global Pandemic Influenza Vaccine Revenue by Application (2026-2031)

5.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Pandemic Influenza Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Company Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sanofi Pandemic Influenza Vaccine Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 CSL

6.2.1 CSL Company Information

6.2.2 CSL Description and Business Overview

6.2.3 CSL Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 CSL Pandemic Influenza Vaccine Product Portfolio

6.2.5 CSL Recent Developments/Updates

6.3 GSK

6.3.1 GSK Company Information

6.3.2 GSK Description and Business Overview

6.3.3 GSK Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 GSK Pandemic Influenza Vaccine Product Portfolio

6.3.5 GSK Recent Developments/Updates

6.4 Viatris

6.4.1 Viatris Company Information

6.4.2 Viatris Description and Business Overview

6.4.3 Viatris Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Viatris Pandemic Influenza Vaccine Product Portfolio

6.4.5 Viatris Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Company Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 AstraZeneca Pandemic Influenza Vaccine Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Hualan Bio

6.6.1 Hualan Bio Company Information

6.6.2 Hualan Bio Description and Business Overview

6.6.3 Hualan Bio Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Hualan Bio Pandemic Influenza Vaccine Product Portfolio

6.6.5 Hualan Bio Recent Developments/Updates

6.7 Changchun Institute of Biological

6.7.1 Changchun Institute of Biological Company Information

6.7.2 Changchun Institute of Biological Description and Business Overview

6.7.3 Changchun Institute of Biological Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Changchun Institute of Biological Pandemic Influenza Vaccine Product Portfolio

6.7.5 Changchun Institute of Biological Recent Developments/Updates

6.8 Sinovac

6.8.1 Sinovac Company Information

6.8.2 Sinovac Description and Business Overview

6.8.3 Sinovac Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sinovac Pandemic Influenza Vaccine Product Portfolio

6.8.5 Sinovac Recent Developments/Updates

6.9 BCHT

6.9.1 BCHT Company Information

6.9.2 BCHT Description and Business Overview

6.9.3 BCHT Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 BCHT Pandemic Influenza Vaccine Product Portfolio

6.9.5 BCHT Recent Developments/Updates

6.10 Jiangsu GDK

6.10.1 Jiangsu GDK Company Information

6.10.2 Jiangsu GDK Description and Business Overview

6.10.3 Jiangsu GDK Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Jiangsu GDK Pandemic Influenza Vaccine Product Portfolio

6.10.5 Jiangsu GDK Recent Developments/Updates

6.11 KM Biologics

6.11.1 KM Biologics Company Information

6.11.2 KM Biologics Description and Business Overview

6.11.3 KM Biologics Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.11.4 KM Biologics Pandemic Influenza Vaccine Product Portfolio

6.11.5 KM Biologics Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pandemic Influenza Vaccine Industry Chain Analysis

7.2 Pandemic Influenza Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pandemic Influenza Vaccine Production Mode & Process Analysis

7.4 Pandemic Influenza Vaccine Sales and Marketing

7.4.1 Pandemic Influenza Vaccine Sales Channels

7.4.2 Pandemic Influenza Vaccine Distributors

7.5 Pandemic Influenza Vaccine Customer Analysis

8 Pandemic Influenza Vaccine Market Dynamics

8.1 Pandemic Influenza Vaccine Industry Trends

8.2 Pandemic Influenza Vaccine Market Drivers

8.3 Pandemic Influenza Vaccine Market Challenges

8.4 Pandemic Influenza Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Changchun Institute of Biological

List of Tables

Table 1. Global Pandemic Influenza Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pandemic Influenza Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Pandemic Influenza Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Pandemic Influenza Vaccine Sales (M Units) of Key Manufacturers (2020-2025)

Table 5. Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Pandemic Influenza Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Pandemic Influenza Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Pandemic Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Pandemic Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pandemic Influenza Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pandemic Influenza Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Pandemic Influenza Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pandemic Influenza Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pandemic Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Pandemic Influenza Vaccine Sales by Region (2020-2025) & (M Units)

Table 18. Global Pandemic Influenza Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Pandemic Influenza Vaccine Sales by Region (2026-2031) & (M Units)

Table 20. Global Pandemic Influenza Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Pandemic Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Pandemic Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Pandemic Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Pandemic Influenza Vaccine Sales by Country (2020-2025) & (M Units)

Table 27. North America Pandemic Influenza Vaccine Sales by Country (2026-2031) & (M Units)

Table 28. North America Pandemic Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Pandemic Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Pandemic Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Pandemic Influenza Vaccine Sales by Country (2020-2025) & (M Units)

Table 32. Europe Pandemic Influenza Vaccine Sales by Country (2026-2031) & (M Units)

Table 33. Europe Pandemic Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Pandemic Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Pandemic Influenza Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Pandemic Influenza Vaccine Sales by Region (2020-2025) & (M Units)

Table 37. Asia Pacific Pandemic Influenza Vaccine Sales by Region (2026-2031) & (M Units)

Table 38. Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Pandemic Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Pandemic Influenza Vaccine Sales by Country (2020-2025) & (M Units)

Table 42. Latin America Pandemic Influenza Vaccine Sales by Country (2026-2031) & (M Units)

Table 43. Latin America Pandemic Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pandemic Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Pandemic Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2020-2025) & (M Units)

Table 47. Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2026-2031) & (M Units)

Table 48. Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Pandemic Influenza Vaccine Sales (M Units) by Type (2020-2025)

Table 51. Global Pandemic Influenza Vaccine Sales (M Units) by Type (2026-2031)

Table 52. Global Pandemic Influenza Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Pandemic Influenza Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Pandemic Influenza Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Pandemic Influenza Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Pandemic Influenza Vaccine Price (US$/Unit) by Type (2020-2025)

Table 59. Global Pandemic Influenza Vaccine Price (US$/Unit) by Type (2026-2031)

Table 60. Global Pandemic Influenza Vaccine Sales (M Units) by Application (2020-2025)

Table 61. Global Pandemic Influenza Vaccine Sales (M Units) by Application (2026-2031)

Table 62. Global Pandemic Influenza Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Pandemic Influenza Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Pandemic Influenza Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Pandemic Influenza Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Pandemic Influenza Vaccine Price (US$/Unit) by Application (2020-2025)

Table 69. Global Pandemic Influenza Vaccine Price (US$/Unit) by Application (2026-2031)

Table 70. Sanofi Company Information

Table 71. Sanofi Description and Business Overview

Table 72. Sanofi Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Sanofi Pandemic Influenza Vaccine Product

Table 74. Sanofi Recent Developments/Updates

Table 75. CSL Company Information

Table 76. CSL Description and Business Overview

Table 77. CSL Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. CSL Pandemic Influenza Vaccine Product

Table 79. CSL Recent Developments/Updates

Table 80. GSK Company Information

Table 81. GSK Description and Business Overview

Table 82. GSK Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. GSK Pandemic Influenza Vaccine Product

Table 84. GSK Recent Developments/Updates

Table 85. Viatris Company Information

Table 86. Viatris Description and Business Overview

Table 87. Viatris Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Viatris Pandemic Influenza Vaccine Product

Table 89. Viatris Recent Developments/Updates

Table 90. AstraZeneca Company Information

Table 91. AstraZeneca Description and Business Overview

Table 92. AstraZeneca Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. AstraZeneca Pandemic Influenza Vaccine Product

Table 94. AstraZeneca Recent Developments/Updates

Table 95. Hualan Bio Company Information

Table 96. Hualan Bio Description and Business Overview

Table 97. Hualan Bio Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Hualan Bio Pandemic Influenza Vaccine Product

Table 99. Hualan Bio Recent Developments/Updates

Table 100. Changchun Institute of Biological Company Information

Table 101. Changchun Institute of Biological Description and Business Overview

Table 102. Changchun Institute of Biological Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Changchun Institute of Biological Pandemic Influenza Vaccine Product

Table 104. Changchun Institute of Biological Recent Developments/Updates

Table 105. Sinovac Company Information

Table 106. Sinovac Description and Business Overview

Table 107. Sinovac Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Sinovac Pandemic Influenza Vaccine Product

Table 109. Sinovac Recent Developments/Updates

Table 110. BCHT Company Information

Table 111. BCHT Description and Business Overview

Table 112. BCHT Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. BCHT Pandemic Influenza Vaccine Product

Table 114. BCHT Recent Developments/Updates

Table 115. Jiangsu GDK Company Information

Table 116. Jiangsu GDK Description and Business Overview

Table 117. Jiangsu GDK Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Jiangsu GDK Pandemic Influenza Vaccine Product

Table 119. Jiangsu GDK Recent Developments/Updates

Table 120. KM Biologics Company Information

Table 121. KM Biologics Description and Business Overview

Table 122. KM Biologics Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. KM Biologics Pandemic Influenza Vaccine Product

Table 124. KM Biologics Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Pandemic Influenza Vaccine Distributors List

Table 128. Pandemic Influenza Vaccine Customers List

Table 129. Pandemic Influenza Vaccine Market Trends

Table 130. Pandemic Influenza Vaccine Market Drivers

Table 131. Pandemic Influenza Vaccine Market Challenges

Table 132. Pandemic Influenza Vaccine Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pandemic Influenza Vaccine

Figure 2. Global Pandemic Influenza Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pandemic Influenza Vaccine Market Share by Type: 2024 & 2031

Figure 4. Trivalent Influenza Vaccine Product Picture

Figure 5. Quadrivalent Influenza Vaccine Product Picture

Figure 6. Global Pandemic Influenza Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Pandemic Influenza Vaccine Market Share by Application: 2024 & 2031

Figure 8. 6 Months to 3 Years

Figure 9. > 3 Years

Figure 10. Global Pandemic Influenza Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Pandemic Influenza Vaccine Market Size (2020-2031) & (US$ Million)

Figure 12. Global Pandemic Influenza Vaccine Sales (2020-2031) & (M Units)

Figure 13. Global Pandemic Influenza Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 14. Pandemic Influenza Vaccine Report Years Considered

Figure 15. Pandemic Influenza Vaccine Sales Share by Manufacturers in 2024

Figure 16. Global Pandemic Influenza Vaccine Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Pandemic Influenza Vaccine Players: Market Share by Revenue in Pandemic Influenza Vaccine in 2024

Figure 18. Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Pandemic Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Pandemic Influenza Vaccine Sales Market Share by Country (2020-2031)

Figure 21. North America Pandemic Influenza Vaccine Revenue Market Share by Country (2020-2031)

Figure 22. United States Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Pandemic Influenza Vaccine Sales Market Share by Country (2020-2031)

Figure 25. Europe Pandemic Influenza Vaccine Revenue Market Share by Country (2020-2031)

Figure 26. Germany Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Region (2020-2031)

Figure 33. China Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America Pandemic Influenza Vaccine Sales Market Share by Country (2020-2031)

Figure 41. Latin America Pandemic Influenza Vaccine Revenue Market Share by Country (2020-2031)

Figure 42. Mexico Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Country (2020-2031)

Figure 46. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Country (2020-2031)

Figure 47. Turkey Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. UAE Pandemic Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Global Sales Market Share of Pandemic Influenza Vaccine by Type (2020-2031)

Figure 51. Global Revenue Market Share of Pandemic Influenza Vaccine by Type (2020-2031)

Figure 52. Global Pandemic Influenza Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 53. Global Sales Market Share of Pandemic Influenza Vaccine by Application (2020-2031)

Figure 54. Global Revenue Market Share of Pandemic Influenza Vaccine by Application (2020-2031)

Figure 55. Global Pandemic Influenza Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 56. Pandemic Influenza Vaccine Value Chain

Figure 57. Channels of Distribution (Direct Vs Distribution)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions